The Nicotinic α5 Subunit Can Replace Either an Acetylcholine-Binding or Nonbinding Subunit in the α4β2* Neuronal Nicotinic Receptor

Molecular Pharmacology

Volumn 85, Issue 1, 2014, Pages 11-17

  Jin, Xiaochun ^a   Bermudez, Isabel ^b   Steinbach, Joe Henry ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN SUBUNIT; XENOPUS;

EID: 84890676531     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.089979     Document Type: Article

References (23)

1. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, Saccone NL, Saccone SF, Bertelsen S, and Fox L et al. (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171.
2. Boulter J, O'Shea-Greenfield A, Duvoisin RM, Connolly JG, Wada E, Jensen A, Gardner PD, Ballivet M, Deneris ES, and McKinnon D et al. (1990) a 3, a 5, and b 4: Three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem 265:4472-4482.
3. Brown RW, Collins AC, Lindstrom JM, and Whiteaker P (2007) Nicotinic a5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem 103:204-215.
4. Carbone AL, Moroni M, Groot-Kormelink PJ, and Bermudez I (2009) Pentameric concatenated (a4)(2)(b2)(3) and (a4)(3)(b2)(2) nicotinic acetylcholine receptors: Subunit arrangement determines functional expression. Br J Pharmacol 156: 970-981.
5. Curtis L, Buisson B, Bertrand S, and Bertrand D (2002) Potentiation of human a4b2 neuronal nicotinic acetylcholine receptor by estradiol. Mol Pharmacol 61:127-135.
6. Exley R, McIntosh JM, Marks MJ, Maskos U, and Cragg SJ (2012) Striatal a5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci 32:2352-2356.
7. Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, and Tsetlin V et al. (2011) Aversion to nicotine is regulated by the balanced activity of b4 and a5 nicotinic receptor subunits in the medial habenula. Neuron 70:522-535.
8. Gerzanich V, Wang F, Kuryatov A, and Lindstrom J (1998) a 5 Subunit alters desensitization, pharmacology, Ca11 permeability and Ca11 modulation of human neuronal a 3 nicotinic receptors. J Pharmacol Exp Ther 286:311-320.
9. Gotti C, Moretti M, Gaimarri A, Zanardi A, Clementi F, and Zoli M (2007) Heterogeneity and complexity of native brain nicotinic receptors. Biochem Pharmacol 74: 1102-1111.
10. Groot-Kormelink PJ, Boorman JP, and Sivilotti LG (2001) Formation of functional a3b4a5 human neuronal nicotinic receptors in Xenopus oocytes: A reporter mutation approach. Br J Pharmacol 134:789-796.
11. Harpsøe K, Ahring PK, Christensen JK, Jensen ML, Peters D, and Balle T (2011) Unraveling the high-and low-sensitivity agonist responses of nicotinic acetylcholine receptors. J Neurosci 31:10759-10766.
12. Jin X and Steinbach JH (2011) A portable site: A binding element for 17b-estradiol can be placed on any subunit of a nicotinic a4b2 receptor. J Neurosci 31: 5045-5054.
13. Kishi M and Steinbach JH (2006) Role of the agonist binding site in up-regulation of neuronal nicotinic a4b2 receptors. Mol Pharmacol 70:2037-2044.
14. Kuryatov A, Onksen J, and Lindstrom J (2008) Roles of accessory subunits in a4b2(*) nicotinic receptors. Mol Pharmacol 74:132-143.
15. Mao D, Perry DC, Yasuda RP, Wolfe BB, and Kellar KJ (2008) The a4b2a5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 104:446-456.
16. Mazzaferro S, Benallegue N, Carbone A, Gasparri F, Vijayan R, Biggin PC, Moroni M, and Bermudez I (2011) Additional acetylcholine (ACh) binding site at a4/a4 interface of (a4b2)2a4 nicotinic receptor influences agonist sensitivity. J Biol Chem 286:31043-31054.
17. Moroni M, Zwart R, Sher E, Cassels BK, and Bermudez I (2006) a4b2 nicotinic receptors with high and low acetylcholine sensitivity: Pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:755-768.
18. Nelson ME, Kuryatov A, Choi CH, Zhou Y, and Lindstrom J (2003) Alternate stoichiometries of a4b2 nicotinic acetylcholine receptors. Mol Pharmacol 63:332-341.
19. Paradiso K, Zhang J, and Steinbach JH (2001) The C terminus of the human nicotinic a4b2 receptor forms a binding site required for potentiation by an estrogenic steroid. J Neurosci 21:6561-6568.
20. Smulders CJ, Zwart R, Bermudez I, van Kleef RG, Groot-Kormelink PJ, and Vijverberg HP (2005) Cholinergic drugs potentiate human nicotinic a4b2 acetylcholine receptors by a competitive mechanism. Eur J Pharmacol 509: 97-108.
21. Zhou Y, Nelson ME, Kuryatov A, Choi C, Cooper J, and Lindstrom J (2003) Human a4b2 acetylcholine receptors formed from linked subunits. J Neurosci 23: 9004-9015.
22. Zwart R, Broad LM, Xi Q, Lee M, Moroni M, Bermudez I, and Sher E (2006) 5-I A-85380 and TC-2559 differentially activate heterologously expressed a4b2 nicotinic receptors. Eur J Pharmacol 539:10-17.
23. Zwart R and Vijverberg HP (1997) Potentiation and inhibition of neuronal nicotinic receptors by atropine: Competitive and noncompetitive effects. Mol Pharmacol 52: 886-895.